- Editorial
- Open access
- Published:
Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
Echo Research & Practice volume 2, pages E1–E7 (2015)
References
Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS 2014 Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. Journal of the American College of Cardiology 64 83–99. (doi:10.1016/j.jacc.2014.05.003)
Shah PM, Gramiak R, Kramer DH 1969 Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 40 3–11. (doi:10.1161/01.CIR.40.1.3)
Williams LK, Gruner CH, Rakowski H 2015 The role of echocardiography in hypertrophic cardiomyopathy. Current Cardiology Reports 17 560 (doi:10.1007/s11886-014-0560-x)
Prasad K, Atherton J, Smith GC, McKenna WJ, Frenneaux MP, Nihoyannopoulos P 1999 Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy. Heart 82 (Suppl 3) III8–III15. (doi:10.1136/hrt.82.2008.iii8)
Blankstein R, Rowin EJ 2014 What is the best imaging test for patients with hypertrophic cardiomyopathy? It depends on the clinical question! Journal of Cardiovascular Computed Tomography 8 438–441. (doi:10.1016/j.jcct.2014.10.003)
Maron MS 2012 Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Journal of Cardiovascular Magnetic Resonance 14 13 (doi:10.1186/1532-429X-14-13)
Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE 1995 Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults. Circulation 92 785–789. (doi:10.1161/01.CIR.92.4.785)
Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, Goldstein SA, Hung J, Maron MS, Ommen SR et al. 2011 American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. Journal of the American Society of Echocardiography 24 473–498. (doi:10.1016/j.echo.2011.03.006)
Sherrid MV, Chaudhry FA, Swistel DG 2003 Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Annals of Thoracic Surgery 75 620–632. (doi:10.1016/S0003-4975(02)04546-0)
Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ et al. 2009 Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. Journal of the American College of Cardiology 54 220–228. (doi:10.1016/j.jacc.2009.05.006)
Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology 58 e212–e260. (doi:10.1016/j.jacc.2011.06.011)
Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal 35 2733–2779. (doi:10.1093/eurheartj/ehu284)
McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J 1981 Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. American Journal of Cardiology 47 532–538. (doi:10.1016/0002-9149(81)90535-X)
Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F 2003 Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology 41 315–321. (doi:10.1016/S0735-1097(02)02713-4)
Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH III 1998 Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 98 1750–1755. (doi:10.1161/01.CIR.98.17.1750)
McIntosh CL, Maron BJ 1988 Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 78 487–495. (doi:10.1161/01.CIR.78.3.487)
Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ 2008 Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118 1541–1549. (doi:10.1161/CIRCULATIONAHA.108.781401)
Kaple RK, Murphy RT, DiPaola LM, Houghtaling PL, Lever HM, Lytle BW, Blackstone EH, Smedira NG 2008 Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Annals of Thoracic Surgery 85 1527–1535, 1535.e1–1535.e2. (doi:10.1016/j.athoracsur.2008.01.061)
Austin BA, Kwon DH, Smedira NG, Thamilarasan M, Lever HM, Desai MY 2009 Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography 22 105e5–105e6. (doi:10.1016/j.echo.2008.10.022)
Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ 2003 Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. New England Journal of Medicine 348 295–303. (doi:10.1056/NEJMoa021332)
Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ 2006 Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 2232–2239. (doi:10.1161/CIRCULATIONAHA.106.644682)
Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ 2006 Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114 216–225. (doi:10.1161/CIRCULATIONAHA.105.583500)
Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR Jr Tajik AJ 1996 Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. Journal of the American College of Cardiology 28 1226–1233. (doi:10.1016/S0735-1097(96)00315-4)
Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG 2014 Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circulation. Cardiovascular Imaging 7 11–19. (doi:10.1161/CIRCIMAGING.113.000842)
Maron MS, Pandian NG 2010 Risk stratification in hypertrophic cardiomyopathy: is two-dimensional echocardiographic strain ready for prime time? Journal of the American Society of Echocardiography 23 591–594. (doi:10.1016/j.echo.2010.04.002)
Maron MS, Hauser TH, Dubrow E, Horst TA, Kissinger KV, Udelson JE, Manning WJ 2007 Right ventricular involvement in hypertrophic cardiomyopathy. American Journal of Cardiology 100 1293–1298. (doi:10.1016/j.amjcard.2007.05.061)
Malik R, Maron MS, Rastegar H, Pandian NG 2014 Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction. Echocardiography 31 682–685. (doi:10.1111/echo.12543)
Ramamurthi A, Aker EM, Pandian NG 2012 A case of aortic stenosis and hypertrophic cardiomyopathy. Echocardiography 29 1261–1263. (doi:10.1111/j.1540-8175.2012.01812.x)
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the articles Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articles Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pandian, N.G., Rowin, E.J., Gonzalez, A.M.G. et al. Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion. Echo Res Pract 2, E1–E7 (2015). https://doi.org/10.1530/ERP-15-0009
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1530/ERP-15-0009